endralazine and Hypertension
endralazine has been researched along with Hypertension in 26 studies
*Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. [MeSH]
Research
Studies (26)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 26 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Bogers, WA; Holmes, DG; Huunan-Seppala, A; Wideroe, B; Wideroe, TE | 1 |
Bogers, WA; Meems, L | 2 |
Gerber, W; Pally, C; Salzmann, R; Scholtysik, G | 1 |
Reubi, FC; Wegmüller, E | 1 |
Hoffmann, JJ; Thien, T; van T'Laar, A | 1 |
Blaha, M; Dvorák, I; Dvorák, M; Havlát, F; Kubesová, H; Nĕmcová, H | 1 |
Kilic, S | 1 |
Fet'kovská, N; Tison, P | 1 |
Rawat, R; Seedat, YK | 1 |
Elliott, HL; Howden, CW; Lawrie, CB; Meredith, PA; Reid, JL | 1 |
Elliott, HL; Meredith, PA; Reid, JL | 1 |
Smits, JF; Struyker-Boudier, HA; van Essen, H | 1 |
Izotov, AI; Postol'nikov, SF; Vygodin, VA | 1 |
Donnelly, RJ; Elliott, HL; McLean, K; Reid, JL; Sumner, DJ | 1 |
Elliott, HL; Kelman, AW; McSharry, DR; Meredith, PA; Reid, JL | 1 |
Glöckner, WM; Kindler, J; Konrads, A; Meurer, KA; Schulz, V; Sieberth, HG; Vaith, P | 1 |
Hochrein, H; Lehmann, HU; Meyer-Estorf, G | 1 |
Hochrein, H; Lehmann, HU; Witt, E | 1 |
Hartmann, HG; Schumacher, H | 1 |
McGourty, JC; Pidgeon, J; Silas, JH | 1 |
Chazan, BI; Duff, DA; McCallum, A; Whaley, K | 1 |
Hauger-Klevene, JH; Mayer, E; Reader, C; Sanchez, MR | 1 |
Izotov, AI; Malysheva, NV; Postol'nikov, SF | 1 |
Carruthers, SG; Spence, JD; Wu, R | 1 |
Kindler, J; Moedder, G; Sieberth, HG | 1 |
Trials
11 trial(s) available for endralazine and Hypertension
Article | Year |
---|---|
Endralazine, a new peripheral vasodilator: absence of effect of acetylator status on antihypertensive effect.
Topics: Acetylation; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Female; Genes; Humans; Hydralazine; Hydrazones; Hypertension; Male; Pindolol; Pyridazines | 1983 |
[Experience with endralazine in the treatment of essential hypertension].
Topics: Antihypertensive Agents; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Pyridazines | 1984 |
[Systolic hypertension. Treatment with endralazine].
Topics: Aged; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Middle Aged; Pyridazines; Systole | 1983 |
[Endralazine in the treatment of hypertension].
Topics: Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Middle Aged; Pyridazines | 1984 |
A dose-finding study of the combination of pindolol, clopamide and endralazine in the treatment of moderate-to-severe hypertension.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Clopamide; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Pyridazines; Time Factors | 1984 |
[Methodologic approach to individual evaluation of the pharmacodynamic effects of single doses of hydralazine, endralazine, prazosine and propranolol in hypertension patients].
Topics: Adult; Antihypertensive Agents; Cardiac Output; Cardiography, Impedance; Humans; Hydralazine; Hypertension; Kinetics; Middle Aged; Prazosin; Propranolol; Pyridazines; Vascular Resistance | 1984 |
[Management of treatment-resistant hypertension: comparison of the antihypertensive effect of endralazine and minoxidil (author's transl)].
Topics: Adolescent; Adult; Aged; Female; Humans; Hypertension; Hypertension, Renal; Male; Middle Aged; Minoxidil; Pyridazines; Pyrimidines; Sleep Wake Disorders | 1981 |
Comparison of once daily endralazine with placebo in the treatment of hypertension uncontrolled by a beta-blocker and diuretic.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Placebos; Posture; Pyridazines; Random Allocation; Time Factors | 1985 |
Comparative study of endralazine and hydralazine for the treatment of hypertension uncontrolled by a beta-blocker and diuretic.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antibodies, Antinuclear; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Pyridazines; Random Allocation | 1986 |
A comparative study of endralazine and captopril in essential hypertension: effect on renin levels, pulmonary function studies and lipid profile.
Topics: Antihypertensive Agents; Blood Pressure; Captopril; Drug Evaluation; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Pyridazines; Random Allocation; Renin; Respiratory Function Tests | 1986 |
[Endralazine monotherapy in comparison with prazosin and hydralazine in arterial hypertension].
Topics: Adult; Clinical Trials as Topic; Humans; Hydralazine; Hypertension; Male; Middle Aged; Prazosin; Pyridazines | 1986 |
Other Studies
15 other study(ies) available for endralazine and Hypertension
Article | Year |
---|---|
Endralazine and acetylator phenotype.
Topics: Acetylation; Antihypertensive Agents; Humans; Hypertension; Phenotype; Pyridazines | 1983 |
Effects of the vasodilator endralazine given with the antihypertensive agent guanfacine on heart rate and blood pressure of spontaneously hypertensive rats and normotensive dogs.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Dogs; Drug Therapy, Combination; Guanfacine; Guanidines; Heart Rate; Hypertension; Male; Phenylacetates; Pyridazines; Rats; Rats, Inbred Strains; Vasodilator Agents | 1983 |
Changes in renal function induced by endralazine, a new antihypertensive drug.
Topics: Aldosterone; Antihypertensive Agents; Blood Pressure; Female; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Kidney; Kidney Function Tests; Male; Middle Aged; Natriuresis; Potassium; Pyridazines; Renal Circulation; Renin; Urea | 1983 |
Effects of intravenous endralazine in essential hypertension.
Topics: Adult; Aldosterone; Antihypertensive Agents; Blood Pressure; Epinephrine; Female; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Pyridazines; Renin; Time Factors | 1983 |
Clinical pharmacological studies with the vasodilator endralazine in normotensive subjects and essential hypertensives.
Topics: Adult; Blood Pressure; Heart Rate; Humans; Hypertension; Kinetics; Male; Pyridazines; Vasodilator Agents | 1984 |
Pharmacodynamic and pharmacokinetic studies with the vasodilator endralazine.
Topics: Adult; Blood Pressure; Drug Evaluation; Humans; Hypertension; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Pyridazines; Random Allocation; Time Factors; Vasodilator Agents | 1984 |
Hemodynamic effects of the arteriolar vasodilators hydralazine, dihydralazine and endralazine in the conscious spontaneously hypertensive rat.
Topics: Animals; Denervation; Dihydralazine; Hemodynamics; Hydralazine; Hypertension; Male; Pressoreceptors; Pyridazines; Rats; Vasodilator Agents | 1983 |
Clinical evaluation of endralazine (BO22708), a new vasodilator, in essential hypertension.
Topics: Adult; Aged; Blood Pressure; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Pyridazines; Renin; Vasodilator Agents | 1982 |
Endralazine, a new peripheral vasodilator. Evaluation of safety and efficacy over a 3 year period.
Topics: Acetylation; Adult; Aged; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Phenotype; Pindolol; Pyridazines; Time Factors; Vasodilator Agents | 1983 |
The pharmacokinetics of endralazine in essential hypertensives and in normotensive subjects.
Topics: Acetylation; Administration, Oral; Aged; Antihypertensive Agents; Female; Humans; Hypertension; Injections, Intravenous; Kinetics; Male; Middle Aged; Pyridazines | 1983 |
[Clinical effectiveness of BQ 22-708, a pyridopyridazine derivative, in the treatment of fixed essential hypertension].
Topics: Drug Evaluation; Female; Heart Rate; Humans; Hypertension; Male; Pyridazines | 1978 |
[Evaluation of a pyridopyridazine as a drug with marked antihypertensive properties (author's transl)].
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Capillaries; Cardiac Output; Female; Heart Failure; Heart Rate; Humans; Hypertension; Male; Middle Aged; Pulmonary Artery; Pyridazines; Vascular Resistance | 1977 |
[Antihypertensive pharmacotherapy with the vasodilators captopril and endralazine].
Topics: Adrenergic beta-Antagonists; Adult; Captopril; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Proline; Pyridazines; Vasodilator Agents | 1985 |
Evaluation of once daily endralazine in hypertension.
Topics: Acetylation; Adult; Aged; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Pyridazines | 1986 |
Tissue distribution of endralazine and its clinical effect in refractory hypertension.
Topics: Animals; Antihypertensive Agents; Autoradiography; Blood Pressure; Carbon Radioisotopes; Clonidine; Female; Humans; Hypertension; Hypertension, Renal; Male; Mice; Pregnancy; Prospective Studies; Pyridazines; Tissue Distribution | 1985 |